biosimilars
6 results
State fails to save millions on HSE medicines bill
- Health & Pharma
- February 8, 2019, 05:55
(...) 2017 to target 50 per cent of prescriptions in hospitals of biosimilars – “copycat”drugs with no(...)
Big Pharma bids to build bridges in Ireland
- Health & Pharma
- November 3, 2018, 05:10
(...) policy on biosimilars remains just that – a promise. The consultation process is complete, but there is(...)
Biosimilar drug to save HSE millions of euro this year
- Health & Pharma
- October 28, 2016, 20:13
(...) medicine is a cheaper identical “copy” of a branded traditional small-molecule drug, biosimilars are “me(...)
‘Biosimilar blocker’ clause could cost HSE over €50m a year
- Health & Pharma
- July 7, 2016, 06:42
(...) beginning to see competition from “biosimilars”. Large molecule protein drugs, biologics cannot be precisely(...)
Generic drugs lobby criticises new agreement
- Health & Pharma
- July 6, 2016, 01:00
(...) four years. However, a lobby group representing the makers of generics and “biosimilars” – copies of(...)
Germany’s Merck stakes out ground in fledgling biosimilars market
- Health & Pharma
- February 10, 2014, 01:30
(...) of competition.Karl-Ludwig Kley, chief executive of the German group, said he expected “biosimilars(...)
